{
  "title": "Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER",
  "itunes:title": "Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER",
  "pubDate": "Mon, 04 Oct 2021 16:00:00 +0000",
  "guid": "55c03b20-66b3-45bf-a128-ce5fac69a6c8",
  "link": "https://psychopharmacology.libsyn.com/nonadherence-adverse-drug-reactions-and-measuring-perceived-side-effects-with-fibser",
  "itunes:image": "",
  "description": "<p>This episode discusses an algorithm for assessing adherence; the reasons for suboptimal adherence, including adverse drug reactions; measuring perceived side effects with the FIBSER scale; and how to help individuals communicate with providers about side effects.</p> <p>Faculty: Martha Sajatovic, M.D.<br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC114\"> <strong>Learn more about our memberships here</strong></a></li> <li><strong><a href= \"https://psychopharmacologyinstitute.com/publication/psychotropic-drug-adherence-2606?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC114\"> Earn 1 CME: Psychotropic Drug Adherence</a></strong></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/nonadherence-adverse-drug-reactions-measuring-perceived-side-effects-with-fibser-and-communication-about-side-effects-2606-5039?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC114\"> <strong>Nonadherence: Adverse Drug Reactions, Measuring Perceived Side Effects With FIBSER, and Communication About Side Effects</strong></a></li> </ul>",
  "content:encoded": "<p>This episode discusses an algorithm for assessing adherence; the reasons for suboptimal adherence, including adverse drug reactions; measuring perceived side effects with the FIBSER scale; and how to help individuals communicate with providers about side effects.</p> <p>Faculty: Martha Sajatovic, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC114\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/psychotropic-drug-adherence-2606?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC114\"> Earn 1 CME: Psychotropic Drug Adherence</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/nonadherence-adverse-drug-reactions-measuring-perceived-side-effects-with-fibser-and-communication-about-side-effects-2606-5039?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC114\"> Nonadherence: Adverse Drug Reactions, Measuring Perceived Side Effects With FIBSER, and Communication About Side Effects</a></li> </ul>",
  "enclosure": "",
  "itunes:duration": "10:27",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "This episode discusses an algorithm for assessing adherence; the reasons for suboptimal adherence, including adverse drug reactions; measuring perceived side effects with the FIBSER scale; and how to help individuals communicate with providers about...",
  "itunes:episodeType": "full"
}